Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-05-000010

VP Finance, Chief Acct.Officer bought 1,500 shares at $7.51 ($11,265)

  • VP Finance, Chief Acct.Officer acquired 136 shares (code I)

From the SEC's structured data for this filing

Trades in this filing

Titus Gary · VP Finance, Chief Acct.Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2004-11-30 Other acquisition : show line 1 in the form +136 $7.69 $1,046 379 D
2005-02-23 Purchase : show line 2 in the form +1,500 $7.51 $11,265 1,879 D
Open-market purchases · 1,500 sh · avg $7.51 · $11,265
Loading xslF345X02/edgar.xml…